Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Stock
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
23.5K
-
Shares change
-
-7.27M
-
Total reported value, excl. options
-
$72K
-
Value change
-
-$1.2M
-
Number of sells
-
-35
-
Price
-
$3.07
Significant Holders of VYNE THERAPEUTICS INC COM - Stock (VYNE) as of Q1 2023
37 filings reported holding VYNE - VYNE THERAPEUTICS INC COM - Stock as of Q1 2023.
VYNE THERAPEUTICS INC COM - Stock (VYNE) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.5K shares
.
Largest 10 shareholders include STALEY CAPITAL ADVISERS INC (23.5K shares), WELLS FARGO & COMPANY/MN (0 shares), RENAISSANCE TECHNOLOGIES LLC (0 shares), STATE STREET CORP (0 shares), FIRST MANHATTAN CO. LLC. (0 shares), FEDERATED HERMES, INC. (0 shares), NORTHERN TRUST CORP (0 shares), FRANKLIN RESOURCES INC (0 shares), DSC Advisors, L.P. (0 shares), and Mariner, LLC (0 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.